Global Epigenetic Market Growth (Status and Outlook) 2024-2030

March 2024 | 84 pages | ID: GA3AF4E42826EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Epigenetic market size will reach US$ 11100 million by 2030.

Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.

The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.

This report presents a comprehensive overview, market shares, and growth opportunities of Epigenetic market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Reagents
• Kits
• Instruments
• Enzymes
• Services

Segmentation by Application:

• Academic Research Institutes
• Biotechnology Companies
• Biopharmaceutical Companies
• Diagnostic Companies

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Illumina
• Qiagen
• Abcam
• Merck & Co
• Sigma-Aldrich
• New England Biolabs
• Thermo Fisher Scientific
• Diagenode
• Active Motif
• Roche Diagnostics
• Eisai
• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Epigenetic Market Size 2024-2030
  2.1.2 Epigenetic Market Size CAGR by Region
2.2 Epigenetic Segment by Type
  2.2.1 Reagents
  2.2.2 Kits
  2.2.3 Instruments
  2.2.4 Enzymes
  2.2.5 Services
2.3 Epigenetic Market Size by Type
  2.3.1 Global Epigenetic Market Size Market Share by Type (2024-2030)
  2.3.2 Global Epigenetic Market Size Growth Rate by Type (2024-2030)
2.4 Epigenetic Segment by Application
  2.4.1 Academic Research Institutes
  2.4.2 Biotechnology Companies
  2.4.3 Biopharmaceutical Companies
  2.4.4 Diagnostic Companies
2.5 Epigenetic Market Size by Application
  2.5.1 Global Epigenetic Market Size Market Share by Application (2024-2030)
  2.5.2 Global Epigenetic Market Size Growth Rate by Application (2024-2030)

3 EPIGENETIC KEY PLAYERS

3.1 Date of Key Players Enter into Epigenetic
3.2 Key Players Epigenetic Product Offered
3.3 Key Players Epigenetic Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Epigenetic Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 EPIGENETIC BY REGIONS

4.1 Epigenetic Market Size by Regions (2024-2030)
4.2 United States Epigenetic Market Size Growth (2024-2030)
4.3 China Epigenetic Market Size Growth (2024-2030)
4.4 Europe Epigenetic Market Size Growth (2024-2030)
4.5 Rest of World Epigenetic Market Size Growth (2024-2030)

5 UNITED STATES

5.1 United States Epigenetic Market Size by Type (2024-2030)
5.2 United States Epigenetic Market Size by Application (2024-2030)

6 EUROPE

6.1 Europe Epigenetic Market Size by Type (2024-2030)
6.2 Europe Epigenetic Market Size by Application (2024-2030)

7 CHINA

7.1 China Epigenetic Market Size by Type (2024-2030)
7.2 China Epigenetic Market Size by Application (2024-2030)

8 REST OF WORLD

8.1 Rest of World Epigenetic Market Size by Type (2024-2030)
8.2 Rest of World Epigenetic Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN EPIGENETIC

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Illumina
  11.1.1 Illumina Company Details
  11.1.2 Illumina Epigenetic Product Offered
  11.1.3 Illumina Epigenetic Market Size (2024 VS 2030)
  11.1.4 Illumina Main Business Overview
  11.1.5 Illumina News
11.2 Qiagen
  11.2.1 Qiagen Company Details
  11.2.2 Qiagen Epigenetic Product Offered
  11.2.3 Qiagen Epigenetic Market Size (2024 VS 2030)
  11.2.4 Qiagen Main Business Overview
  11.2.5 Qiagen News
11.3 Abcam
  11.3.1 Abcam Company Details
  11.3.2 Abcam Epigenetic Product Offered
  11.3.3 Abcam Epigenetic Market Size (2024 VS 2030)
  11.3.4 Abcam Main Business Overview
  11.3.5 Abcam News
11.4 Merck & Co
  11.4.1 Merck & Co Company Details
  11.4.2 Merck & Co Epigenetic Product Offered
  11.4.3 Merck & Co Epigenetic Market Size (2024 VS 2030)
  11.4.4 Merck & Co Main Business Overview
  11.4.5 Merck & Co News
11.5 Sigma-Aldrich
  11.5.1 Sigma-Aldrich Company Details
  11.5.2 Sigma-Aldrich Epigenetic Product Offered
  11.5.3 Sigma-Aldrich Epigenetic Market Size (2024 VS 2030)
  11.5.4 Sigma-Aldrich Main Business Overview
  11.5.5 Sigma-Aldrich News
11.6 New England Biolabs
  11.6.1 New England Biolabs Company Details
  11.6.2 New England Biolabs Epigenetic Product Offered
  11.6.3 New England Biolabs Epigenetic Market Size (2024 VS 2030)
  11.6.4 New England Biolabs Main Business Overview
  11.6.5 New England Biolabs News
11.7 Thermo Fisher Scientific
  11.7.1 Thermo Fisher Scientific Company Details
  11.7.2 Thermo Fisher Scientific Epigenetic Product Offered
  11.7.3 Thermo Fisher Scientific Epigenetic Market Size (2024 VS 2030)
  11.7.4 Thermo Fisher Scientific Main Business Overview
  11.7.5 Thermo Fisher Scientific News
11.8 Diagenode
  11.8.1 Diagenode Company Details
  11.8.2 Diagenode Epigenetic Product Offered
  11.8.3 Diagenode Epigenetic Market Size (2024 VS 2030)
  11.8.4 Diagenode Main Business Overview
  11.8.5 Diagenode News
11.9 Active Motif
  11.9.1 Active Motif Company Details
  11.9.2 Active Motif Epigenetic Product Offered
  11.9.3 Active Motif Epigenetic Market Size (2024 VS 2030)
  11.9.4 Active Motif Main Business Overview
  11.9.5 Active Motif News
11.10 Roche Diagnostics
  11.10.1 Roche Diagnostics Company Details
  11.10.2 Roche Diagnostics Epigenetic Product Offered
  11.10.3 Roche Diagnostics Epigenetic Market Size (2024 VS 2030)
  11.10.4 Roche Diagnostics Main Business Overview
  11.10.5 Roche Diagnostics News
11.11 Eisai
11.12 Novartis

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Epigenetic Market Size CAGR by Region (2024-2030) ($ Millions)
Table 2. Major Players of Reagents
Table 3. Major Players of Kits
Table 4. Major Players of Instruments
Table 5. Major Players of Enzymes
Table 6. Major Players of Services
Table 7. Global Epigenetic Market Size by Type (2024-2030) ($ Millions)
Table 8. Global Epigenetic Market Size Market Share by Type (2024-2030)
Table 9. Global Epigenetic Market Size by Application (2024-2030) ($ Millions)
Table 10. Global Epigenetic Market Size Market Share by Application (2024-2030)
Table 11. Date of Global Key Players Enter into Epigenetic Market
Table 12. Global Key Players Epigenetic Product Offered
Table 13. Key Players Epigenetic Funding/Investment ($ Millions)
Table 14. Funding/Investment by Regions
Table 15. Funding/Investment by End Industry
Table 16. Key Players Epigenetic Valuation & Market Capitalization ($ Millions)
Table 17. Key Players Mergers & Acquisitions, Expansion Plans
Table 18. Epigenetic New Product/Technology Launches
Table 19. Epigenetic Industry Partnerships, Agreements, and Collaborations
Table 20. Epigenetic Industry Mergers and Acquisitions
Table 21. Global Epigenetic Market Size by Regions 2024-2030 ($ Millions)
Table 22. Global Epigenetic Market Size Market Share by Regions 2024-2030
Table 23. United States Epigenetic Market Size by Type (2024-2030) ($ Millions)
Table 24. United States Epigenetic Market Size Market Share by Type (2024-2030)
Table 25. United States Epigenetic Market Size by Application (2024-2030) ($ Millions)
Table 26. United States Epigenetic Market Size Market Share by Application (2024-2030)
Table 27. Europe Epigenetic Market Size by Type (2024-2030) ($ Millions)
Table 28. Europe Epigenetic Market Size Market Share by Type (2024-2030)
Table 29. Europe Epigenetic Market Size by Application (2024-2030) ($ Millions)
Table 30. Europe Epigenetic Market Size Market Share by Application (2024-2030)
Table 31. China Epigenetic Market Size by Type (2024-2030) ($ Millions)
Table 32. China Epigenetic Market Size Market Share by Type (2024-2030)
Table 33. China Epigenetic Market Size by Application (2024-2030) ($ Millions)
Table 34. China Epigenetic Market Size Market Share by Application (2024-2030)
Table 35. Rest of World Epigenetic Market Size by Type (2024-2030) ($ Millions)
Table 36. Rest of World Epigenetic Market Size Market Share by Type (2024-2030)
Table 37. Rest of World Epigenetic Market Size by Application (2024-2030) ($ Millions)
Table 38. Rest of World Epigenetic Market Size Market Share by Application (2024-2030)
Table 39. Key Market Drivers & Growth Opportunities of Epigenetic
Table 40. Key Market Challenges & Risks of Epigenetic
Table 41. Key Industry Trends of Epigenetic
Table 42. Company A Company Details
Table 43. Companies Invested by Company A
Table 44. Company A Key Development and Market Layout
Table 45. Company B Company Details
Table 46. Companies Invested by Company B
Table 47. Company B Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Illumina Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Illumina Epigenetic Market Size (2024 VS 2030)
Table 56. Qiagen Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Qiagen Epigenetic Market Size (2024 VS 2030)
Table 58. Abcam Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Abcam Epigenetic Market Size (2024 VS 2030)
Table 60. Merck & Co Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. Merck & Co Epigenetic Market Size (2024 VS 2030)
Table 62. Sigma-Aldrich Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Sigma-Aldrich Epigenetic Market Size (2024 VS 2030)
Table 64. New England Biolabs Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. New England Biolabs Epigenetic Market Size (2024 VS 2030)
Table 66. Thermo Fisher Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Thermo Fisher Scientific Epigenetic Market Size (2024 VS 2030)
Table 68. Diagenode Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Diagenode Epigenetic Market Size (2024 VS 2030)
Table 70. Active Motif Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Active Motif Epigenetic Market Size (2024 VS 2030)
Table 72. Roche Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Roche Diagnostics Epigenetic Market Size (2024 VS 2030)
Table 74. Eisai Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Eisai Epigenetic Market Size (2024 VS 2030)
Table 76. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Novartis Epigenetic Market Size (2024 VS 2030)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Epigenetic
Figure 2. Epigenetic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Epigenetic Market Size Growth Rate 2024-2030 ($ Millions)
Figure 7. Epigenetic Market Size by Region (2024 & 2030) ($ millions)
Figure 8. Global Epigenetic Market Size Market Share by Type (2024-2030)
Figure 9. Global Reagents Market Size Growth Rate
Figure 10. Global Kits Market Size Growth Rate
Figure 11. Global Instruments Market Size Growth Rate
Figure 12. Global Enzymes Market Size Growth Rate
Figure 13. Global Services Market Size Growth Rate
Figure 14. Epigenetic in Academic Research Institutes
Figure 15. Global Epigenetic Market: Academic Research Institutes (2024-2030) ($ Millions)
Figure 16. Epigenetic in Biotechnology Companies
Figure 17. Global Epigenetic Market: Biotechnology Companies (2024-2030) ($ Millions)
Figure 18. Epigenetic in Biopharmaceutical Companies
Figure 19. Global Epigenetic Market: Biopharmaceutical Companies (2024-2030) ($ Millions)
Figure 20. Epigenetic in Diagnostic Companies
Figure 21. Global Epigenetic Market: Diagnostic Companies (2024-2030) ($ Millions)
Figure 22. Global Epigenetic Market Size Market Share by Application (2024-2030)
Figure 23. Global Epigenetic Market Size in Academic Research Institutes Growth Rate
Figure 24. Global Epigenetic Market Size in Biotechnology Companies Growth Rate
Figure 25. Global Epigenetic Market Size in Biopharmaceutical Companies Growth Rate
Figure 26. Global Epigenetic Market Size in Diagnostic Companies Growth Rate
Figure 27. Funding/Investment
Figure 28. Global Epigenetic Market Size Market Share by Regions 2024-2030
Figure 29. United States Epigenetic Market Size 2024-2030 ($ Millions)
Figure 30. China Epigenetic Market Size 2024-2030 ($ Millions)
Figure 31. Europe Epigenetic Market Size 2024-2030 ($ Millions)
Figure 32. Rest of World Epigenetic Market Size 2024-2030 ($ Millions)
Figure 33. United States Epigenetic Consumption Market Share by Type in 2030
Figure 34. United States Epigenetic Market Size Market Share by Application in 2030
Figure 35. China Epigenetic Consumption Market Share by Type in 2030
Figure 36. China Epigenetic Market Size Market Share by Application in 2030
Figure 37. Europe Epigenetic Consumption Market Share by Type in 2030
Figure 38. Europe Epigenetic Market Size Market Share by Application in 2030
Figure 39. Rest of World Epigenetic Consumption Market Share by Type in 2030
Figure 40. Rest of World Epigenetic Market Size Market Share by Application in 2030